Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Albireo Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Albireo Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Chiswell David | Director | 0 | Mar 3, 2023 | 0 |
| Carter Martha J. | Chief Regulatory Officer | 3,654 | Mar 2, 2023 | 0 |
| Scoon Davey | Director | – | Mar 2, 2023 | 0 |
| Harford Simon N.R. | CFO and Treasurer | 0 | Mar 2, 2023 | 0 |
| Graham Michelle | Chief Human Resources Officer | 0 | Mar 2, 2023 | 0 |
| Cooper Ronald Harold Wilfred | President and CEO | 0 | Mar 2, 2023 | 0 |
| Gutch Michael | Director | – | Mar 2, 2023 | 0 |
| Mattsson Jan | Chief Scientific Officer | 0 | Mar 2, 2023 | 0 |
| Dable Habib J | Director | – | Mar 2, 2023 | 0 |
| Streck Paul | Chief Medical Officer | 118,966 | Mar 2, 2023 | 0 |
| Hopkinson Craig C. | Director | 10,495 | Mar 2, 2023 | 0 |
| Duncan Jason | Chief Legal Officer and GC | 0 | Mar 2, 2023 | 0 |
| Okey Stephanie | Director | – | Mar 2, 2023 | 0 |
| Stephenson Pamela | Chief Commercial Officer | 0 | Mar 2, 2023 | 0 |
| Alesina Susan | Director | – | Mar 2, 2023 | 0 |
| Edelman Joseph | 10% Owner | 1,939,723Indirect | Oct 13, 2022 | 0 |
| Perceptive Advisors LLC | 10% Owner | 1,939,723Indirect | Oct 13, 2022 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | 1,939,723Indirect | Oct 13, 2022 | 0 |
| Horn Patrick Taylor | Chief Medical Officer | 12,355 | Oct 25, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2021 (view filing) | Dec 27 | Same day | Stephenson PamelaChief Commercial Officer | SSale | −474 | $23.92 | −$11.3K | −1.8%25.6K after | |
| Oct 25, 2021 (view filing) | Oct 22 | 3 days | Horn Patrick TaylorChief Medical Officer | SSale | −95 | $28.83 | −$2.74K | −0.8%12.4K after | |
| Oct 25, 2021 (view filing) | Oct 22-25 | 3 days | Duncan JasonChief Legal Officer and GC | SSale | −312 | $29.10 | −$9.08K | −4.1%7.36K after | 2 lots |
| Oct 12, 2021 (view filing) | Oct 11 | 1 day | Harford Simon N.R.CFO and Treasurer | SSale | −93 | $30.23 | −$2.81K | −0.7%12.6K after | |
| Sep 28, 2021 (view filing) | Sep 27 | 1 day | Stephenson PamelaChief Commercial Officer | SSale | −451 | $32.05 | −$14.5K | −1.7%26.1K after | |
| Jul 26, 2021 (view filing) | Jul 22 | 4 days | Horn Patrick TaylorChief Medical Officer | SSale | −90 | $34.13 | −$3.07K | −0.7%12.4K after | |
| Jul 26, 2021 (view filing) | Jul 22-23 | 4 days | Duncan JasonChief Legal Officer and GC | SSale | −313 | $32.21 | −$10.1K | −3.9%7.67K after | 2 lots |
| Jul 15, 2021 (view filing) | Jul 13 | 2 days | Harford Simon N.R.CFO and Treasurer | SSale | −98 | $35.02 | −$3.43K | −0.8%12.7K after |